Feedback / Questions
Eylea (aflibercept intravitreal) - Bayer, Regeneron
OPT-302 - Opthea
Lucentis (ranibizumab) - Roche, Novartis
https://www.biospace.com/article/releases/opthea-expands-global-phase-3-shore-and-coast-wet-amd-trials-of-opt-302-into-canada/
Aug 9, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next